StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > NO volume

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on Oct 12, 2021 9:59pm

179 Views

Post# 33999526

RE:NO volume

4real4ever wrote: Dou you remember $1,60 few months ago?

Not really. That price was only for a few hours of one day, based on hype...
None of us grownups really took it seriously.
What we take seriously is the opportunity to average down drastically before this thing runs up again.
Because it will, now that SZLS has consolidated its business plan and opened up its revenue streams.
Every serious analyst agrees.
Hehehehe.
GLTA longs! *wink!